- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
IT
Eli Lilly counts up Sixty8 Capital contribution
Eli Lilly has helped Sixty8 Capital hold a first close for its $20m fund, which the venture capital firm will use to back startups led by members of typically underrepresented communities.
May 12, 2021Safar Partners attracts $191m
The venture fund, focused on companies out of MIT, Harvard and Rochester, has collected more than $191m on its way to a $325m target.
May 11, 2021Daily Deal Round Up: May 10, 2021
Legend Holdings' Legend Star unit led a round for optical chip producer Turing Quantum sized above $15m while several Japanese companies also raised money.
May 10, 2021Lightmatter illuminates $80m series B
The photonic computing technology spinout of MIT has now pocketed $113m in funding altogether.
May 10, 2021Corporates illuminate Lightmatter in $80m series B
Alphabet, Hewlett Packard Enterprise and Lockheed Martin invested in the photonic computing technology developer’s series B round, increasing its total funding to $113m.
May 10, 2021Analysis: Solid Power with a $130m recharge
Solid-state battery developer Solid Power secured a $130 series B round co-led by its potential customers from the automotive sector BMW and Ford Motor Company.
May 10, 2021Daily deal net: May 7, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
May 7, 2021Vast Data vaults to $83m series D
Nvidia participated in a round valuing the data storage technology provider, which counts Dell, Siemens and Mellanox as investors, at $3.7bn.
May 7, 2021Daily Deal Round Up: May 6, 2021
Opioid addiction care provider Groups Recover Together and healthcare management platform developer Vim each raised $60m, with Optum Ventures backing both rounds.
May 6, 2021Subsector: healthcare IT and administration
A decade or more after setting up the golden age of corporate venturing units were set up with a focus on life sciences and healthcare, such as US-listed conglomerate Alphabet’s GV (formerly known as Google Ventures) and US-listed drugs company Merck’s Global Health Innovation Fund (GHIF), and the returns have surpassed many expectations.
May 6, 2021AEye amends reverse merger deal downwards
The corporate-backed lidar technology provider will now be valued at $1.52bn pre-acquisition rather than the $1.9bn figure when the deal was announced in February.
May 6, 2021Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


